Search research articles
Contact Us
Filters
Showing results (1121-1130 of 1,216) with videos related to
Page
of 122
Sort By:
The Lancet. Oncology
|
September 3, 2013
Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group
Nancy U Lin, Jeffrey S Wefel, Eudocia Q Lee, et al.
JAMA Oncology
|
November 29, 2016
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
JCO Precision Oncology
|
September 30, 2021
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma
Jessica L Fleming, Stephanie L Pugh, Barbara J Fisher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2021
Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma
Kirit Singh, Kristen A Batich, Patrick Y Wen, et al.
JCO Oncology Practice
|
May 11, 2022
Implementation Strategies to Increase Clinical Trial Enrollment in a Community-Academic Partnership and Impact on Hispanic Representation: An Interrupted Time Series Analysis
Nahomy Ledesma Vicioso, Diana Lin, Daniel R Gomez, et al.
Neuro-Oncology
|
January 25, 2020
Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients
Eudocia Q Lee, Michael Weller, Joohee Sul, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 7, 2016
The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
JAMA Oncology
|
June 30, 2018
Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial
Erica H Bell, Peixin Zhang, Barbara J Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 8, 2025
Dual Immune Check Point Blockade in <i>MGMT</i>-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial
Andrew B Lassman, Mei-Yin C Polley, Fabio M Iwamoto, et al.
Science Signaling
|
December 17, 2009
EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy
Deliang Guo, Robert M Prins, Julie Dang, et al.
Page
of 122
Search research articles
Search
Showing results (1121-1130 of 1,216) with videos related to
Sort By:
Page
of 122
The Lancet. Oncology
|
September 3, 2013
Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group
Nancy U Lin, Jeffrey S Wefel, Eudocia Q Lee, et al.
JAMA Oncology
|
November 29, 2016
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
JCO Precision Oncology
|
September 30, 2021
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma
Jessica L Fleming, Stephanie L Pugh, Barbara J Fisher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2021
Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma
Kirit Singh, Kristen A Batich, Patrick Y Wen, et al.
JCO Oncology Practice
|
May 11, 2022
Implementation Strategies to Increase Clinical Trial Enrollment in a Community-Academic Partnership and Impact on Hispanic Representation: An Interrupted Time Series Analysis
Nahomy Ledesma Vicioso, Diana Lin, Daniel R Gomez, et al.
Neuro-Oncology
|
January 25, 2020
Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients
Eudocia Q Lee, Michael Weller, Joohee Sul, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 7, 2016
The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
JAMA Oncology
|
June 30, 2018
Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial
Erica H Bell, Peixin Zhang, Barbara J Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 8, 2025
Dual Immune Check Point Blockade in <i>MGMT</i>-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial
Andrew B Lassman, Mei-Yin C Polley, Fabio M Iwamoto, et al.
Science Signaling
|
December 17, 2009
EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy
Deliang Guo, Robert M Prins, Julie Dang, et al.
Page
of 122